Working to Eradicate Gynecologic Cancers

Giovanni Scambia, PhD

Full Professor
Catholic University of the Sacred Heart
Largo A. Gemelli
1
Milan Italy 20123

Papers:
4 Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of concept 67 Chemoradiation vs. neoadjuvant chemoradiation followed by radical surgery for FIGO stage III cervical cancer: analysis of complications and 3-year survival 282 Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer 309 Comparison of quality of life after secondary cytoreductive surgery (SCS) ± HIPEC in recurrent ovarian cancer 329 Role of PDZ binding kinase (PBK) associated to guanylate binding protein 1 (GBP1) for drug resistance in ovarian cancer 330 The ratio between type 1 and type 2 tumor-associated macrophages predicts prognosis in patients with locally advanced cervical cancer receiving chemoradiation 366 Minimally invasive interval debulking surgery in AEOC: preliminary results from the MISSION trial 418 The GRO-SNaPET study: preliminary data on the prediction of lymphonodal status by sentinel lymph node biopsy combined with 18FDG-PET/CT to overcome the current limits of vulvar cancer treatment Application of the laparoscopic predictive model for the prediction of complete cytoreduction in advanced epithelial ovarian cancer: the ‘Fagotti Score’ TELELAP ALF-X assisted laparoscopy for total hysterectomy: first human report LEG VIDEO ENDOSCOPIC GROIN LYMPHADENECTOMY IN VULVAR CANCER Phase III SCORPION trial (ID number: NCT01461850) in epithelial ovarian cancer patients with high tumor load receiving PDS versus NACT: ad interim analysis on peri-operative outcome